| Mon, Oct 5, 2009 | | • | Homeland Security TV Features Generex Executive to Discuss H1N1 Preparedness and Related Biological Security Issues
GlobeNewswire (Mon, Oct 5)
| | Thu, Oct 1, 2009 | | • | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Other Events
EDGAR Online (Thu, Oct 1)
| | Wed, Sep 30, 2009 | | • | Generex Presents Abstracts At Scientific Symposium in Europe
GlobeNewswire (Wed, Sep 30)
| | • | StockPreacher.com Issues Trading Outlook for Generex Biotechnology Corp.
GlobeNewswire (Wed, Sep 30)
| | Fri, Sep 25, 2009 | | • | StockPreacher.com Issues Trading Outlook for Novadel Pharma Inc.
GlobeNewswire (Fri, Sep 25)
| | Thu, Sep 24, 2009 | | • | Emerging Stock Report Initiates Independent Research Coverage On Generex Biotechnology Corp.
GlobeNewswire (Thu, Sep 24)
| | Tue, Sep 22, 2009 | | • | Generex MENA Broadens International Reach
GlobeNewswire (Tue, Sep 22)
| | Tue, Sep 15, 2009 | | • | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E
EDGAR Online (Tue, Sep 15)
| | Mon, Sep 14, 2009 | | • | Generex to Raise $12,250,000 in Registered Direct Offering
GlobeNewswire (Mon, Sep 14)
| | Fri, Sep 11, 2009 | | • | Skymark Research Initiates Independent Research Coverage On Generex Biotechnology Corp.
GlobeNewswire (Fri, Sep 11)
| | • | Globalequityreport.com Announces An Investment Report Featuring Biopharmaceutical Company Generex Biotechnology Corp.
GlobeNewswire (Fri, Sep 11)
| | Thu, Sep 10, 2009 | | • | Generex Announces USFDA Approval of Use of Company's Flagship Buccal Insulin Product, Generex Oral-lyn(TM), Under the USFDA'S Treatment Investigational New Drug (IND) Program
GlobeNewswire (Thu, Sep 10)
| | Tue, Sep 8, 2009 | | • | Generex to Present At Rodman & Renshaw Annual Global Investment Conference
GlobeNewswire (Tue, Sep 8)
| | Wed, Sep 2, 2009 | | • | Generex Establishes European Subsidiary
GlobeNewswire (Wed, Sep 2)
| | Thu, Aug 27, 2009 | | • | Generex Biotechnology Corporation's Synthetic Vaccine Platform Represented At International Swine Flu Conference
GlobeNewswire (Thu, Aug 27)
| | Mon, Aug 24, 2009 | | • | Generex Biotechnology CEO Anna Gluskin Featured On BNN News to Discuss Potential for H1N1 Vaccine
GlobeNewswire (Mon, Aug 24)
| | Tue, Aug 18, 2009 | | • | Generex Announces Sales Agreement With McCarthy and Sons Service
GlobeNewswire (Tue, Aug 18)
| | Thu, Aug 6, 2009 | | • | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E
EDGAR Online (Thu, Aug 6)
| | • | Generex Raises $5.65 Million in a Registered Direct Offering of Common Stock
GlobeNewswire (Thu, Aug 6)
| | Wed, Aug 5, 2009 | | • | Generex Announces Publication of Pre-Clinical Studies Demonstrating Utility of Its Vaccine Platform for Addressing Pandemic Influenza
GlobeNewswire (Wed, Aug 5)
| | Tue, Aug 4, 2009 | | • | Amgen Co-founder to Act as Generex Chief Scientific Advisor
GlobeNewswire (Tue, Aug 4)
| | Mon, Aug 3, 2009 | | • | Generex Reports Annual Meeting Resulted in Shareholders Passing All Proxy Proposals With Strong Support
GlobeNewswire (Mon, Aug 3)
| | Mon, Jul 27, 2009 | | • | Beacon Equity Issues Trading Outlook for Generex Biotechnology Corp.
GlobeNewswire (Mon, Jul 27)
| | Wed, Jul 22, 2009 | | • | Generex Announces Plans to File An Investigational New Drug (IND) With the Veterinary Drugs Directorate of Health Canada in Anticipation of a New Drug Submission for Generex Oral-lyn(tm)
GlobeNewswire (Wed, Jul 22)
| | Mon, Jul 20, 2009 | | • | Generex Publishes Results From Pre-Clinical Studies On Immunotherapeutic Vaccine for HPV-Induced Cervical Cancer
GlobeNewswire (Mon, Jul 20)
|
Add GNBT News to My Yahoo!:
 
| |
|
0.09% Nasdaq 
0.35%
Headlines
